Riskpilot← Back to searchSign inGet full accessLinMar AB
ABActiveOrg 5591234827StockholmMedical specialists activities · NACE 8622Est. 20170 employees
Revenue 2024
SEK 437K
+212% vs 2023
EBITDA margin
82.4%
+219% vs 2023
Equity ratio
85.2%
Financial strength
Net profit 2024
SEK -298K
-504% vs 2023
| Revenue | SEK 437K | +212% |
| EBITDA | SEK 360K | +219% |
| Net profit | SEK -298K | -504% |
| Total assets | SEK 1,1M | -17% |
| Equity | SEK 948K | -24% |
| Employees | 0 | — |
Legal name
LinMar AB
Org number
5591234827
Legal form
Aktiebolag
NACE code
8622 · Medical specialists activities
Founded
31 augusti 2017
Share capital
SEK 50 000
Employees
0
VAT registered
Yes
Audit selected
No
Last report
2024-12-31
Financial year
January – December
Signatory rights
Firman tecknas av styrelsen
Company purpose
Föremålet för bolagets verksamhet skall vara att bedriva läkarverksamhet, medicinsk konsult-, forsknings- och utbildningsverksamhet samt rådgivning inom hälso- och sjukvård, friskvård, rehabilitering samt kring kost- och livsstilsfrågor även även kliniska prövningar samt deltagande vid kurser, kongresser även bedriva litterärt och konstnärligt skapande som bl.a. bloggskrivande och musikproduktion samt erbjuda discjockeytjänster och vidare även äga och förvalta värdepapper, fast och lös egendom samt därmed förenlig verksamhet.
Address
Stockholm
Email
linmarab@gmail.com
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Revenue | 3 899 | 0 | 0 | 140 | 437 |
| Staff expenses | — | — | −0 | −0 | — |
| EBITDA | 288 | −413 | −27 | 113 | 360 |
| Depreciation & amort. | −6 | −6 | −6 | −6 | −10 |
| EBIT | 282 | −419 | −33 | 107 | 350 |
| Net financials | 119 | 1 911 | −120 | −16 | −1 152 |
| Profit before tax | 401 | 1 491 | −146 | 91 | −226 |
| Tax | −86 | −288 | — | −17 | −72 |
| Net profit | 315 | 1 203 | −146 | 74 | −298 |
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Total assets | 819 | 1 643 | 1 247 | 1 345 | 1 113 |
| Equity | 504 | 1 317 | 1 172 | 1 245 | 948 |
| Long-term debt | 0 | 0 | — | — | 0 |
| Short-term debt | 307 | 318 | 76 | 100 | 165 |
| Total debt | 307 | 318 | 76 | 100 | 165 |
EBITDA margin
82.4%
This company
15.8%
Market median
+422% vs market
20202024
Equity ratio
85.2%
This company
38.2%
Market median
+123% vs market
20202024
Return on equity
-31.4%
This company
18.4%
Market median
-271% vs market
20202024
Net profit margin
-68.2%
This company
8.1%
Market median
-942% vs market
20202024
Asset turnover
0.39×
This company
1.12×
Market median
-65% vs market
20202024
Debt / equity
0.17×
This company
0.62×
Market median
+73% vs market
20202024
- Annual report 2024Filed via Bolagsverket / SCB · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via Bolagsverket / SCB · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via Bolagsverket / SCB · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via Bolagsverket / SCB · Period 2021-01-01 – 2021-12-31
- Annual report 2020Filed via Bolagsverket / SCB · Period 2020-01-01 – 2020-12-31
No data on file.
| Name | Role | Member since |
|---|---|---|
| Current (2) | ||
| Deputy Board Member | 2022 | |
| Board of Directors | 2022 | |
No shareholder data available.
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
No registered parent or subsidiaries
Board members of LinMar AB also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Annelie Birgitta Bergens | Deputy Board Member | 0 companies |
| Linus Joakim Mårtensson | Board of Directors | 0 companies |